SB 917 - Dougherty, Pat
Mandates insurance coverage for new phases of clinical trials undertaken for the treatment of cancer
Bill Details
Sponsor
LR Number
2779S.01I
Title
SB 917
House Handler
N/A
Journal Page
S117
Co-Sponsors
Effective Date
August 28, 2004
Current Status
Second Read and Referred S Small Business, Insurance and Industrial Relations Committee
Quick Links
Amendments
No amendments available
CURRENT BILL SUMMARY
SB 917 - This act requires health insurance companies to provide coverage for routine patient care costs incurred as the result of phase I or II clinical trials undertaken to treat cancer. Currently, Section 376.429, RSMo, requires coverage for phases III or IV only.
LORIE TOWE